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Supplementary file 1. Electronic search for the intervention studies including database, 
number of references found, and terms included. 
 
The electronic search was conducted including all the years until 12 December 2020. 
Three categories of search terms were identified: 1) age, 2) type of physical exercise, and 3) 
interventions. Relevant publications that contained at least one term from each of the 3 
categories in the full text, were identified. Moreover, use of the search term, school or 
physical education, was restricted to title and abstract to avoid its inclusion in the author’s 
affiliation. The following terms were used for each category: 
 
a) Web of Science: 555 references  
 
TI= (child OR children OR youth OR student* OR pupil* OR young* OR infant*) AND TI= 
(resistance training OR resistance activity OR resistance exercise OR strength OR Muscle 
Strengthening OR Bone Strengthening OR Strength Training OR Strength Exercise OR Weight 
Training OR Weight Lifting OR Weight Bearing Exercise OR Bodyweight Exercise OR 
Bodyweight Training OR plyometric) AND TS= (trial OR intervention* OR program  OR 
implement* OR evaluat* OR change  OR pilot  OR project  OR encourage* OR planning  OR 
impact) AND TS= (school  OR physical education) 
 
b) SPORT DISCUS: 96 references. 
 
TI ( child  OR children  OR youth  OR student*  OR pupil*  OR young*  OR infant*) AND TI ( 
resistance training OR resistance activity OR resistance exercise OR strength OR Muscle 
Strengthening OR Bone Strengthening OR Strength Training OR Strength Exercise OR Weight 
Training OR Weight Lifting OR Weight Bearing Exercise OR Bodyweight Exercise OR 
Bodyweight Training OR plyometric) AND AB ( trial OR intervention*  OR program  OR 
implement*  OR evaluat*  OR change  OR pilot  OR project  OR encourage*  OR planning  OR 
impact ) AND AB ( school OR physical education ) 
 
c) Scopus: 401 references. 
 
( TITLE-ABS-KEY ( child  OR  children  OR  youth  OR  student*  OR  pupil*  OR  young*  OR  
infant* )  AND  TITLE-ABS-KEY ( resistance  AND training  OR  resistance  AND exercise  OR  
strength  AND training )  AND  TITLE-ABS-KEY ( trial  OR  intervention*  OR  program  OR  
implement*  OR  evaluat*  OR  change  OR  pilot  OR  project  OR  encourage*  OR  
planning  OR  impact )  AND  TITLE-ABS-KEY ( school  OR  physical  AND education ) ) 
 
d) Google Scholar: 500 references* 
 
*First 500 results from Google Scholar were used as per the guidance of Haddaway et al 
(2015). 
 
Haddaway, N. R., Collins, A. M., Coughlin, D., & Kirk, S. (2015). The Role of Google Scholar 
in Evidence Reviews and Its Applicability to Grey Literature Searching. PLoS ONE, 10(9), 
e0138237. http://doi.org/10.1371/journal.pone.0138237 
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Supplementary table 1.  PRISMA 2020 Main and Abstract Checklist. 
Topic No. Item Location where item is reported 
TITLE    
Title 1 Identify the report as a systematic review.  p.1 
ABSTRACT    
Abstract 2 See the PRISMA 2020 for Abstracts checklist  
INTRODUCTION    
Rationale 3 Describe the rationale for the review in the context of existing knowledge.  p.3 
Objectives 4 Provide an explicit statement of the objective(s) or question(s) the review addresses. p.4 
METHODS    
Eligibility criteria 5 Specify the inclusion and exclusion criteria for the review and how studies were grouped for the syntheses. p.4 
Information sources 6 Specify all databases, registers, websites, organisations, reference lists and other sources searched or consulted to 
identify studies. Specify the date when each source was last searched or consulted. 
p.5 
Search strategy 7 Present the full search strategies for all databases, registers and websites, including any filters and limits used. p.5 
Selection process 8 Specify the methods used to decide whether a study met the inclusion criteria of the review, including how many 
reviewers screened each record and each report retrieved, whether they worked independently, and if applicable, 
details of automation tools used in the process. 
p.5 
Data collection process 9 Specify the methods used to collect data from reports, including how many reviewers collected data from each 
report, whether they worked independently, any processes for obtaining or confirming data from study investigators, 
and if applicable, details of automation tools used in the process.  
p.9 
Topic No. Item Location where item is reported 
Data items 10a List and define all outcomes for which data were sought. Specify whether all results that were compatible with each 
outcome domain in each study were sought (e.g. for all measures, time points, analyses), and if not, the methods 
used to decide which results to collect. 
p.9 
 10b List and define all other variables for which data were sought (e.g. participant and intervention characteristics, 
funding sources). Describe any assumptions made about any missing or unclear information. 
p.9 
Study risk of bias 
assessment 
11 Specify the methods used to assess risk of bias in the included studies, including details of the tool(s) used, how many 
reviewers assessed each study and whether they worked independently, and if applicable, details of automation tools 
used in the process.  
p.6 
Effect measures 12 Specify for each outcome the effect measure(s) (e.g. risk ratio, mean difference) used in the synthesis or presentation 
of results. 
p.7 
Synthesis methods 13a Describe the processes used to decide which studies were eligible for each synthesis (e.g. tabulating the study 
intervention characteristics and comparing against the planned groups for each synthesis (item 5)). 
p.7-8 
 13b Describe any methods required to prepare the data for presentation or synthesis, such as handling of missing 
summary statistics, or data conversions. 
p.7-8 
13c Describe any methods used to tabulate or visually display results of individual studies and syntheses. p.7-8 
13d Describe any methods used to synthesize results and provide a rationale for the choice(s). If meta-analysis was 
performed, describe the model(s), method(s) to identify the presence and extent of statistical heterogeneity, and 
software package(s) used. 
p.7-8 
13e Describe any methods used to explore possible causes of heterogeneity among study results (e.g. subgroup analysis, 
meta-regression). 
p.7-8 
13f Describe any sensitivity analyses conducted to assess robustness of the synthesized results. p.7-8 
Reporting bias 
assessment 
14 Describe any methods used to assess risk of bias due to missing results in a synthesis (arising from reporting biases). p.7-8 
Certainty assessment 15 Describe any methods used to assess certainty (or confidence) in the body of evidence for an outcome. p.7-8 
RESULTS    
Topic No. Item Location where item is reported 
Study selection 16a Describe the results of the search and selection process, from the number of records identified in the search to the 
number of studies included in the review, ideally using a flow diagram. 
p.8 
 16b Cite studies that might appear to meet the inclusion criteria, but which were excluded, and explain why they were 
excluded. 
p.8 
Study characteristics 17 Cite each included study and present its characteristics. p.8 
Risk of bias in studies 18 Present assessments of risk of bias for each included study. p.10 
Results of individual 
studies 
19 For all outcomes, present, for each study: (a) summary statistics for each group (where appropriate) and (b) an effect 
estimate and its precision (e.g. confidence/credible interval), ideally using structured tables or plots. 
p.10 
Results of syntheses 20a For each synthesis, briefly summarise the characteristics and risk of bias among contributing studies. p.11-13 
 20b Present results of all statistical syntheses conducted. If meta-analysis was done, present for each the summary 
estimate and its precision (e.g. confidence/credible interval) and measures of statistical heterogeneity. If comparing 
groups, describe the direction of the effect. 
p.11-13 
20c Present results of all investigations of possible causes of heterogeneity among study results. p.11-13 
20d Present results of all sensitivity analyses conducted to assess the robustness of the synthesized results. p.11-13 
Reporting biases 21 Present assessments of risk of bias due to missing results (arising from reporting biases) for each synthesis assessed. p.13 
Certainty of evidence 22 Present assessments of certainty (or confidence) in the body of evidence for each outcome assessed. p.13 
DISCUSSION    
Discussion 23a Provide a general interpretation of the results in the context of other evidence. p.13-17 
 23b Discuss any limitations of the evidence included in the review. p.13-17 
23c Discuss any limitations of the review processes used. p.13-17 
23d Discuss implications of the results for practice, policy, and future research. p.13-17 
Topic No. Item Location where item is reported 
OTHER INFORMATION    
Registration and protocol 24a Provide registration information for the review, including register name and registration number, or state that the 
review was not registered.  
p.4 
 24b Indicate where the review protocol can be accessed, or state that a protocol was not prepared. p.4 
24c Describe and explain any amendments to information provided at registration or in the protocol. p.4 
Support 25 Describe sources of financial or non-financial support for the review, and the role of the funders or sponsors in the 
review. 
p.19 
Competing interests 26 Declare any competing interests of review authors. p.19 
Availability of data, code 
and other materials 
27 Report which of the following are publicly available and where they can be found: template data collection forms; 
data extracted from included studies; data used for all analyses; analytic code; any other materials used in the review. 
- 
 
PRISMA Abstract Checklist 
Topic No. Item Reported? 
TITLE    
Title 1 Identify the report as a systematic review. Yes 
BACKGROUND    
Objectives 2 Provide an explicit statement of the main objective(s) or question(s) the review addresses. Yes 
METHODS    
Eligibility criteria 3 Specify the inclusion and exclusion criteria for the review. Yes 
Topic No. Item Reported? 
Information 
sources 
4 Specify the information sources (e.g. databases, registers) used to identify studies and the date when each was last searched.  Yes 
Risk of bias 5 Specify the methods used to assess risk of bias in the included studies. Yes 
Synthesis of 
results 
6 Specify the methods used to present and synthesize results.  Yes 
RESULTS    
Included studies 7 Give the total number of included studies and participants and summarise relevant characteristics of studies. Yes 
Synthesis of 
results 
8 Present results for main outcomes, preferably indicating the number of included studies and participants for each. If meta-analysis 
was done, report the summary estimate and confidence/credible interval. If comparing groups, indicate the direction of the effect 
(i.e. which group is favoured). 
Yes 
DISCUSSION    
Limitations of 
evidence 
9 Provide a brief summary of the limitations of the evidence included in the review (e.g. study risk of bias, inconsistency and 
imprecision). 
Yes 
Interpretation 10 Provide a general interpretation of the results and important implications. Yes 
OTHER    
Funding 11 Specify the primary source of funding for the review. No 




































































































































































1. Was the study described as randomised, a 
randomised clinical trial, or a RCT? Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes No 
Yes 
1.1 Or did they describe it as cluster 
randomised? NA NA NA Yes Yes Yes Yes NA NA Yes NR Yes NR NR No 
Yes 
2. Was the method of the randomisation 
adequate (i.e., use of randomly generated 
assignment)? 
Yes NR NR NR NR NR Yes NR NR Yes NR Yes NR NR No NR 
3. Was the treatment allocation concealed (so 
that assignments could not be predicted)? Yes NR NR NR NR NR Yes NR NR Yes Yes Yes NR NR NR 
Yes 
4. a) Were study participants blinded to the 
treatment-group assignments? NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
4. b) Were providers blinded to the treatment 
group assignments?  NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
4.1 In case of cluster-randomisation:  Was the 
recruitment of participants conducted by an 
individual independent of the trial?  
NA NA NA Yes NA NA NA NA NA NA NA NA NA NA NA NA 
5. Were the people blinded to the 
participant’s group assignment? No NR No Yes Yes Yes NR Yes Yes Yes NR No No No NR 
NR 
6. Were the groups similar at baseline on 
important characteristics that could affect 
outcomes (i.e., demographics, risk-factors, co-
morbid conditions)? 
Yes Yes Yes Yes Yes Yes No Yes Yes Yes No No No Yes No Yes 
6.1 In case of cluster randomisation: Did they 
use stratification or matched-pairs before 
randomisation to reduce baseline-
imbalances? 
NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR 
7. Was the overall drop-out rate from the 
study at endpoint 20% or lower of the 
number allocated to treatment? 




8. Was the differential drop-out rate 
(between treatment groups) at endpoint 15 
percentage points or lower? 




9. Was there high adherence to the 
intervention protocols for each treatment 
group? 
Yes Yes Yes Yes Yes Yes No Yes Yes Yes NR NR NR NR NR NR 
10. Were other interventions avoided or 
similar in the groups (e.g., similar background 
treatments)? 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
11. Were outcomes assessed using valid and 
reliable measures, implemented consistently 
across all study participants? 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
12. Did the authors report the calculation of a 
sufficiently large sample size to be able to 
detect a difference in the main outcome 
between groups with at least 80% power? 







12.1 a) In case of cluster-randomisation: Did 
they take clustering effects into account in 
their statistical analysis? 
No NA NA Yes Yes Yes No Yes Yes No Yes Yes Yes Yes No Yes 
12.2 b) In case of cluster-randomisation: Did 
they consider intra-class-correlation 
regarding sample size calculation? 
No No No No No No Yes No No No No No No No No No 
13. Were outcomes or analysed subgroups 
which were reported prespecified? (i.e., 
identified before analyses was conducted)? 
Yes No Yes Yes Yes Yes NR Yes Yes Yes Yes Yes Yes Yes NR Yes 
14. Were all randomised participants 
analysed in the group to which they were 
originally assigned, i.e., did they use an 
intention-to-treat analysis? 
Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes 
Quality rating: (good, fair or poor) poor poor fair good good good poor good good poor poor poor poor fair poor good 
*CD, cannot determine; NA, not applicable; NR, not reported 




Supplementary table 3. Quality Assessment for Before-After Studies (Pre-Post) Studies with 











1. Was the study question or objective clearly stated? Yes 
2. Were eligibility/selection criteria for the study population prespecified and clearly described? Yes 
3. Were the participants in the study representative of those who were eligible for the 
test/service/intervention in the general or clinical population of interest? 
No 
4. Were all eligible participants that meet the prespecified entry criteria enrolled? Yes 
5. Was the sample size sufficiently large to provide confidence in the findings? No 
6. Was the test/service/intervention clearly described and delivered consistently across the study 
population? 
Yes 
7. Were the outcome measures prespecified, clearly defined, valid, reliable and assessed 
consistently across all study participants? 
Yes 
8. Were the people assessing the outcomes blinded to the participants' exposure/interventions? NA 
9. Was the loss to follow-up after baseline 20% or less? Were those lost to follow-up accounted for 
in the analysis? 
Yes 
10. Did they use statistical methods that examined changes in outcome measures from before to 
after the intervention? Were statistical tests done that provided p values for the pre-to-post 
changes? 
No 
11. Were outcome measures of interest taken multiple times before the intervention and multiples 
times after the intervention (i.e., did they use an interrupted time-series design)? 
NR 
12. If the intervention was conducted at a group level (e.g., a whole hospital, a community, etc.) did 
the statistical analysis take into account the use of individual-level data to determine effects at the 
group level? 
No 
Quality rating: (good, fair or poor) poor 
NA, not applicable; NR, not reported 
Fatal flaws: If a study has a "fatal flaw," (NO response), then risk of bias is significant, and the study is of poor 
quality. 
 
 
